Our use of cookies
We would like to use necessary cookies to perform the basic functions of this website. Such strictly necessary cookies do not require your consent and are therefore always active. We would also like to set analytical cookies and advertising cookies that help us make improvements by measuring how you use our website. Both the analytical cookies and advertising cookies require your consent and are therefore called “optional cookies”. Detailed information about the use of cookies and how you can control your consent for optional cookies can be found in our Cookie Policy and Privacy Policy.

Hello! We use cookies to help improve your experience of our website. With your consent, statistical and analytical cookies may also be used on this website. If you agree to the use of these additional cookies, please mark your choice:
Back to testimonies

The Human Protein Atlas and Precision Medicine: A Conversation with Mathias Uhlen

08-07-23

Lr5GS7WzakoPAOHB2SbqTzjlvpwMhsVlAe4D54cR.png

In an exclusive interview with NewsMed, Mathias Uhlen, the Director of the Human Protein Atlas, delves into the world of precision medicine and the groundbreaking research being conducted at the Human Protein Atlas.

A Quest to Understand the Human Body

Mathias Uhlen, a professor in Stockholm and the director of the Human Protein Atlas, shares his inspiration for this groundbreaking research. His desire to systematically study the fundamental building blocks of the human body, the proteins, led to the creation of this revolutionary resource for humanity and research purposes. With approximately 20,000 proteins comprising the human body, the Human Protein Atlas aims to comprehensively understand each one and its role in our well-being.

Unveiling the Human Protein Atlas

At a recent presentation at ICG, Mathias Uhlen discussed the monumental achievements of the Human Protein Atlas. With an astounding 15 million web pages and 10 million images, the database is continuously expanding to incorporate more data. Precision medicine takes center stage in their research efforts, utilizing this wealth of knowledge to aid patients in hospitals and even those unaware of their underlying health conditions.

Omics for All: The Path to Meaningful Data

As a scientist, Mathias Uhlen understands the significance of omics, which involves incorporating big data technologies to extract useful information from the abundance of data. With artificial intelligence and machine learning at their disposal, researchers can process vast amounts of data generated by others, turning it into valuable knowledge for all.

Challenges in the Realm of Precision Medicine

Precision medicine holds immense promise to revolutionize healthcare, but it also faces several challenges. Individual differences pose a significant hurdle, as people may respond differently to treatments, leading to varying outcomes. False positives in early detection tests, like those for breast, colon, or prostate cancer, can cause unnecessary distress for patients. Validating screening methods is crucial to ensure accuracy in diagnosing diseases and avoiding misdiagnoses.

The Long Road to Precision Medicine

Although precision medicine has been a compelling field of research for the past few decades, it is still waiting for a groundbreaking breakthrough. Mathias Uhlen highlights the potential of new technologies, such as those developed by MGI, to push precision medicine into the realm of clinical application.

Decoding the Human Proteome: The Importance of the Human Protein Atlas

The Human Protein Atlas project, involving an international collaborative effort, aims to map human proteins comprehensively. This critical endeavor provides life sciences researchers with a blueprint of the human body's building blocks. Researchers gain insights into various organs and tissues, paving the way for drug development, diagnostics, and a deeper understanding of human physiology.

Embracing Open-Access Resources

The Human Protein Atlas stands as one of the most visited life science databases globally, and its success is attributed to its open-access policy. Mathias Uhlen explains the importance of making this resource available worldwide. Unrestricted access ensures that this fundamental knowledge reaches everyone, fostering research and education in the medical and scientific communities.

The Role of MGI Tech in Advancing Research

MGI Tech, a prominent player in the life science industry, has been an essential partner in the Human Protein Atlas project. Their advanced technologies, particularly in DNA sequencing and related areas, have significantly contributed to the project's success.

Pride in Achievements and Future Aspirations

Amidst a diverse career, Mathias Uhlen considers the Human Protein Atlas as one of his proudest achievements. Providing a valuable resource for researchers worldwide, this project continues to thrive and evolve. The focus now lies on expanding research into diseases, tissue profiling, and single-cell technologies.

The Vision for Precision Medicine

Precision medicine continues to hold promise as a revolutionary approach to healthcare. Although it faces challenges, ongoing research, driven by collaborations and cutting-edge technologies, offers hope for a future where precision medicine becomes standard treatment, benefitting patients worldwide.

About MGI

MGI Tech Co., Ltd. (MGI) is committed to building core tools and technology to lead life science through intelligent innovation. Based on its proprietary technology, MGI focuses on research & development, production, and sales of sequencing instruments***, reagents***, and related products to support life science research, agriculture, precision medicine, and healthcare. MGI's mission is to develop and promote advanced life science tools for future healthcare. As of December 2021, MGI has a footprint that spans across more than 80 countries and regions, serves over 1,300 international users, and employs more than 2,050 professionals globally, around 35% of which are R&D personnel. For more information, please visit the MGI website or connect on TwitterLinkedIn, or YouTube.